Subscribe
Sign in
Share this discussion
De-escalation in ≥1% PD-L1 metastatic melanoma: the time has come!
www.drugdevletter.com
Copy link
Facebook
Email
Note
Other
De-escalation in ≥1% PD-L1 metastatic…
Vinay Prasad
May 22
7
Share this post
De-escalation in ≥1% PD-L1 metastatic melanoma: the time has come!
www.drugdevletter.com
Copy link
Facebook
Email
Note
Other
Time to revisit dual checkpoint inhibition based on PD-L1 testing in metastatic melanoma.
Read →
0 Comments
Share
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
De-escalation in ≥1% PD-L1 metastatic melanoma: the time has come!
De-escalation in ≥1% PD-L1 metastatic…
De-escalation in ≥1% PD-L1 metastatic melanoma: the time has come!
Time to revisit dual checkpoint inhibition based on PD-L1 testing in metastatic melanoma.